2045-79-6COc1ccc(CCN)cc1LTPVSOCPYWDIFU-UHFFFAOYSA-N4-methoxyphenylethylamine is a primary amino compound consisting of ethylamine having a 4-methoxyphenyl substituent at the 2-position. It derives from a hydride of a 2-phenylethylamine.
2045-79-6、55-81-2DTXSID6058764CHEMBL101036CHEBI:266039Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 0.9% (1 of 106) of reports.
Danger
H314 (99.1%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
P260, P264, P264+P265, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 106 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
REACH registered substance: p-methoxyphenethylamine (EC: 200-245-5)
2-(4-Methoxyphenyl)-ethylamine: Does not have an individual approval but may be used under an appropriate group standard
Skin Corr. 1C (99.1%)
Skin Corr. 1B (100%)
Uses4-Methoxyphenethylamine an inhibitor of the deamination of tyramine and tryptamine. It is intermediates of ritodrine. ritodrine is an adrenergic β2 receptor agonists used to prevent premature birth.
General Description4-Methoxyphenethylamine inhibits the monoamine oxidase-catalyzed deamination of both tyramine and tryptamine.
Loading…
DefinitionChEBI: 4-methoxyphenylethylamine is a primary amino compound consisting of ethylamine having a 4-methoxyphenyl substituent at the 2-position. It derives from a hydride of a 2-phenylethylamine.